Buys
Open market- Shares
- Avg price
- Total value
Jeff E. Knight - Chief Dev. & Operating Officer at Crinetics Pharmaceuticals, Inc.
Insider Transactions and Holdings
- Entity Type
- Individual
- Role
- Chief Dev. & Operating Officer
- Issuer Symbol
- CRNX on Nasdaq
- All Insider Reports
- All Insider Reports
Jeff E. Knight - trading volume in the past year for Crinetics Pharmaceuticals, Inc.
Sells
Open market- Shares
- -95,074
- Avg price
- $39.82
- Total value
- -$3,785,448
Net
Past year- Shares
- -95,074
- Share %
- -100%
- Total value
- -$3,785,448
Holdings reported by Jeff E. Knight for Crinetics Pharmaceuticals, Inc.
Form 4 holding
Chief Dev. & Operating Officer
Crinetics Pharmaceuticals, Inc.
- Security class
- Common Stock
- Shares / value
- 105,289
- Estimated value
- $4,222,088
- Report date
- 08 Apr 2026
- Price
- $40.10
- Ownership
- Direct
Form 4 holding
Chief Dev. & Operating Officer
Crinetics Pharmaceuticals, Inc.
- Security class
- Stock Option (Right to Buy)
- Shares / value
- 65,977
- Estimated value
- Report date
- 08 Apr 2026
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transactions reported by Jeff E. Knight for Crinetics Pharmaceuticals, Inc.
| Sym | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.